MedPath

A study on global gene expression and circulating mRNA profiling in Esophageal cancer patients

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: C159- Malignant neoplasm of esophagus, unspecified
Registration Number
CTRI/2020/05/025172
Lead Sponsor
Dr Naveena Kumar A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients diagnosed with locally advanced esophageal cancer. Age less than 75 years and more than 18 years. Patients who are willing to give informed consent.

Exclusion Criteria

Metastatic esophageal cancer. Patient not fit for neo-adjuvant chemo-radiation and surgery. Patients with seriously ill conditions and major co-morbidities.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression and mRNA profiling in Indian Esophageal Cancer PatientsTimepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
To assess the survival outcomes in different molecular signatures.Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath